PBAC Public Summary Documents (first time decisions not to recommend, deferrals and other matters) – May 2021 meeting

10 September 2021 - The Public Summary Documents (first time decisions not to recommend, deferrals and other matters) from the May ...

Read more →

Public Summary Documents – May 2021 PBAC meeting

27 August 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the May 2021 PBAC ...

Read more →

Drug Utilisation Subcommittee outcome statement

21 July 2021 - The outcome statement from the June 2021 Drug Utilisation Subcommittee meeting is now available. ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) – March 2021 meeting

16 July 2021 - The Public Summary Documents (first time rejections and deferrals) from the March 2021 PBAC meeting are now ...

Read more →

DUSC utilisation analysis public release documents

13 July 2021 - The utilisation analysis public release documents from the February 2021 DUSC meeting are now available. ...

Read more →

PBAC Public Summary Document for risdiplam – March 2021 meeting

5 July 2021 - The Public Summary Document for risdiplam from the March 2021 PBAC meeting is now available. ...

Read more →

Public Summary Documents (rejections/deferrals/other matters) - December 2020 PBAC intracycle meeting

23 April 2021 - The Public Summary Documents (rejections/deferrals/other matters) from the December 2020 PBAC intracycle meeting are now available. ...

Read more →

PBAC Public Summary Documents - December 2020 intracycle meeting

9 April 2021 - The Public Summary Documents (positive recommendations) from the December 2020 PBAC intracycle meeting are now available. ...

Read more →

PBAC publishes sham Public Summary Document for upadacitinib

22 March 2021 - The outcome section makes absolutely no reference to the issue at hand. ...

Read more →

PBAC Public Summary Documents (first time rejections and deferrals) - November 2020 meeting

19 March 2021 - The Public Summary Documents (first time rejections and deferrals) from the November 2020 PBAC meeting are now ...

Read more →

Drug Utilisation Sub-Committee outcome statement

18 March 2021 - The outcome statement from the February 2021 Drug Utilisation Sub-Committee meeting is now available. ...

Read more →

PBAC updates Public Summary Document for medicine without a published outcome

11 March 2021 - The Department of Health has updated the Public Summary Document for adalimumab (Humira) from the July ...

Read more →

PBAC Public Summary Documents - November 2020 meeting

5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...

Read more →

Post-market review of medicines for smoking cessation – stakeholder forum outcome

15 February 2021 - A stakeholder forum was held for the post-market review of medicines for smoking cessation via webinar on ...

Read more →

PBAC Public Summary Documents (rejections/deferrals/other matters) - September 2020 intracycle meeting

15 January 2021 - The Public Summary Documents (rejections/deferrals/other matters) from the September 2020 PBAC untracycle meeting are now available. ...

Read more →